HAL Id: hal-01762401
https://hal.sorbonne-universite.fr/hal-01762401
Submitted on 10 Apr 2018
HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
Distributed under a Creative Commons Attribution| 4.0 International License
dysregulation in Gaucher disease
Thibaud Lefebvre, Niloofar Reihani, Raed Daher, Thierry Billette de Villemeur, Nadia Belmatoug, Christian Rose, Yves Colin-Aronovicz, Hervé
Puy, Caroline Le van Kim, Mélanie Franco, et al.
To cite this version:
Thibaud Lefebvre, Niloofar Reihani, Raed Daher, Thierry Billette de Villemeur, Nadia Belmatoug,
et al.. Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease. Haematologica,
Ferrata Storti Foundation, 2018, 103 (4), pp.587-596. �10.3324/haematol.2017.177816�. �hal-01762401�
Received: August 1, 2017.
Accepted: January 3, 2018.
Pre-published: January 5, 2018.
©2018 Ferrata Storti Foundation
Material published in Haematologica is covered by copyright.
All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:
https://creativecommons.org/licenses/by-nc/4.0/legalcode.
Copies of published material are allowed for personal or inter- nal use. Sharing published material for non-commercial pur- poses is subject to the following conditions:
https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for com- mercial purposes is not allowed without permission in writing from the publisher.
Correspondence:
zoubida.karim@inserm.fr
Ferrata Storti Foundation
Haematologica 2018 Volume 103(4):587-596
ARTICLE
Bone Marrow Failure
doi:10.3324/haematol.2017.177816
Check the online version for the most updated information on this article, online supplements, and information on authorship & disclosures:
www.haematologica.org/content/103/4/587
G aucher disease (GD) is an inherited deficiency of glucocerebrosi- dase leading to accumulation of glucosylceramide in tissues such as the spleen, liver, and bone marrow. The resulting lipid-laden macrophages lead to the appearance of “Gaucher cells”. Anemia associ- ated with an unexplained hyperferritinemia is a frequent finding in GD, but whether this pathogenesis is related to an iron metabolism disorder has remained unclear. To investigate this issue, we explored the iron sta- tus of a large cohort of 90 type I GD patients, including 66 patients treat- ed with enzyme replacement therapy. Ten of the patients treated with enzyme replacement were followed up before and during treatment.
Serum levels of hepcidin, the iron regulatory peptide, remained within the physiological range, while the transferrin saturation was slightly decreased in children. Inflammation-independent hyperferritinemia was found in 65% of the patients, and Perl’s staining of the spleen and mar- row smear revealed iron accumulation in Gaucher cells. Treated patients exhibited reduced hyperferritinemia, increased transferrin saturation and transiently increased systemic hepcidin. In addition, the hepcidin and ferritin correlation was markedly improved, and, in most patients, the hemoglobin level was normalized. To further explore eventual iron sequestration in macrophages, we produce a Gaucher cells model by treating the J774 macrophage cell line with a glucocerebrosidase inhibitor and showed induced local hepcidin and membrane retrieval of the iron exporter, ferroportin. These data reveal the involvement of Gaucher cells in abnormal iron sequestration, which may explain the mechanism of hyperferritinemia in GD patients. Local hepcidin-ferro- portin interaction was involved in this pathogenesis.
Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease
Thibaud Lefebvre,
1,2*Niloofar Reihani,
3*Raed Daher,
1Thierry Billette de Villemeur,
4Nadia Belmatoug,
5Christian Rose,
6Yves Colin-Aronovicz,
3Hervé Puy,
1,2Caroline Le Van Kim,
3Mélanie Franco
3**and Zoubida Karim
1**1
University Sorbonne Paris Cité, Paris Diderot University, Inserm U1149 / ERL 8252, Inflammation Research Center (CRI), Laboratory of Excellence GR-Ex, Paris;
2
AP-HP, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes;
3
University Sorbonne Paris Cité, Paris Diderot University, Inserm, INTS, “Biologie Intégrée du Globule Rouge” Department, Laboratory of Excellence GR-Ex, Paris;
4
Sorbonne Universités, UPMC, GRC ConCer-LD and AP-HP, Hôpital Trousseau, Service de Neuropédiatrie, Centre de Référence des Maladies Lysosomales, Paris;
5